Buys
Open market- Shares
- Avg price
- Total value
Arjun Agarwal - Senior Vice President, Finance at Oruka Therapeutics, Inc.
Issuer-level insider activity
- Role
- Senior Vice President, Finance
- Issuer ticker
- ORKA on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Arjun Agarwal in Oruka Therapeutics, Inc.
Sells
Open market- Shares
- -42,125
- Avg price
- $79.58
- Total value
- -$3,352,376
Net
Past year- Shares
- -42,125
- Share %
- -100%
- Total value
- -$3,352,376
Reported holdings for Arjun Agarwal in Oruka Therapeutics, Inc.
Form 4 holding
Senior Vice President, Finance
Oruka Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 15,312
- Estimated value
- $1,660,782
- Report date
- 13 Aug 2026
- Price
- $108.46
- Ownership
- Direct
Form 4 holding
Senior Vice President, Finance
Oruka Therapeutics, Inc.
- Security class
- Employee Stock Option (right to buy)
- Shares / value
- 59,792
- Estimated value
- Report date
- 13 Aug 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Arjun Agarwal in Oruka Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.